Effect of intrawound vancomycin powder in operatively treated high-risk tibia fractures: a randomized clinical trial
Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study
Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer
New England Journal of Medicine.
Erlotinib, cabozantinib, or erlotinib plus cabozantinib as second-line or third-line treatment of patients with EGFR wild-type advanced non-small-cell lung cancer (ECOG-ACRIN 1512): a randomised, controlled, open-label, multicentre, phase 2 trial
Biomarker-calibrated dietary energy and protein intake associations with diabetes risk among postmenopausal women from the Women's Health Initiative
American Journal of Clinical Nutrition.
Map of science